Financial Performance - The group's revenue for the fiscal year 2025 was approximately HKD 644.4 million, an increase of about 9.1% compared to fiscal year 2024[3] - The profit attributable to the company's owners for fiscal year 2025 was approximately HKD 26.3 million, an increase of about HKD 2.1 million or approximately 8.9% from fiscal year 2024[3] - Basic earnings per share for fiscal year 2025 were approximately HKD 0.069, compared to HKD 0.064 for fiscal year 2024[5] - Gross profit for fiscal year 2025 was HKD 295.5 million, compared to HKD 269.9 million in fiscal year 2024[4] - The total comprehensive income for the year was HKD 25.2 million, compared to HKD 19.2 million in the previous year[5] - The group reported a pre-tax profit of HKD 29.9 million for fiscal year 2025, compared to HKD 26.6 million for fiscal year 2024[4] - The group reported a net profit of HKD 26.632 million, compared to HKD 24.189 million in the previous year, indicating an increase of about 10.1%[24] - Adjusted profit before tax for the group was HKD 29.942 million, up from HKD 26.564 million, marking a growth of around 9.0%[24] Dividends and Shareholder Returns - The board proposed a final dividend of HKD 0.03 for fiscal year 2025, up from HKD 0.028 in fiscal year 2024[3] - The group proposed a final dividend of HKD 0.03 per share for 2025, compared to HKD 0.028 per share in 2024, totaling HKD 11.4 million for 2025[43] Assets and Liabilities - Non-current assets increased to HKD 484,322,000 in 2025 from HKD 442,759,000 in 2024, representing a growth of 9.5%[6] - Current assets decreased to HKD 587,649,000 in 2025 from HKD 613,614,000 in 2024, a decline of 4.2%[6] - Total liabilities decreased from HKD 215,820,000 in 2024 to HKD 203,721,000 in 2025, a reduction of 5.6%[6] - Non-current liabilities increased to HKD 86,501,000 in 2025 from HKD 73,887,000 in 2024, an increase of 17.0%[7] - Total equity rose to HKD 781,749,000 in 2025 from HKD 766,666,000 in 2024, reflecting a growth of 2.0%[7] - Cash and cash equivalents decreased to HKD 439,903,000 in 2025 from HKD 489,583,000 in 2024, a decline of 10.1%[6] - The group's total liabilities amounted to HKD 290,222,000 in 2025, slightly up from HKD 289,707,000 in 2024[25] Revenue Segmentation - The external customer revenue for the general medical services segment was HKD 410.825 million, up from HKD 398.388 million, indicating a growth of about 3.6%[24] - The specialty medical services segment reported a loss of HKD 13.114 million, an improvement from a loss of HKD 39.270 million in the previous year[24] - The dental services segment generated revenue of HKD 67.757 million, compared to HKD 58.469 million, reflecting an increase of approximately 15.5%[24] - Revenue from primary healthcare services increased by approximately HKD 12.4 million or 3.1% to about HKD 410.8 million in fiscal year 2025, driven by an increase in patient visits and average spending per visit[45] - Revenue from specialist medical services rose by approximately HKD 31.9 million or 23.8% to about HKD 165.8 million in fiscal year 2025, attributed to an increase in patient visits and average spending per visit[45] - Revenue from dental services increased by approximately HKD 9.3 million or 15.9% to about HKD 67.8 million in fiscal year 2025, mainly due to increased patient visits following the acquisition of Youde Dental[45] Operational Efficiency - The group's administrative and other expenses for fiscal year 2025 were HKD 271.7 million, compared to HKD 264.0 million in fiscal year 2024[4] - The group's service costs increased by approximately HKD 28.0 million or 8.7% to about HKD 349.0 million for the fiscal year 2025, primarily due to increased payments to doctors and dentists[46] - Financing costs decreased to HKD 6.6 million in fiscal year 2025 from HKD 8.2 million in fiscal year 2024[4] - The impairment loss on trade receivables decreased to HKD 10.9 million in 2025 from HKD 11.2 million in 2024[41] Acquisitions and Market Position - The group completed the acquisition of Youde Dental in fiscal year 2025, contributing to overall revenue growth in the dental segment despite competitive pressures[59] - The acquisition of Yau Tak Dental was completed, contributing to a revenue of approximately HKD 67.8 million in FY2025, reflecting a year-on-year growth of about 15.9%[65] - The number of dental service points increased from 15 to 35, a 133% rise compared to FY2024, enhancing patient accessibility and market coverage[66] Community Engagement and Health Initiatives - The group actively participated in community health programs in collaboration with the Hong Kong government, including seasonal flu vaccination and chronic disease management initiatives[71] - The group emphasizes good corporate governance and responsible business practices, aiming to create a positive and lasting impact on the community[89] Digital Transformation and Technology Integration - In the fiscal year 2025, the group achieved significant progress in digital transformation, implementing a comprehensive clinic operation system and an all-channel sales platform to enhance customer satisfaction[70] - The group emphasizes the integration of technology into operations to enhance nursing quality and efficiency, reflecting its commitment to improving healthcare services[70] Employee and Governance - The company employed 402 full-time employees and 207 part-time employees as of June 30, 2025, compared to 388 full-time and 355 part-time employees in the previous year[107] - The company has adopted the corporate governance code as per the listing rules and has complied with all applicable provisions for the fiscal year 2025, except for a deviation regarding the separation of the roles of Chairman and CEO[112]
盈健医疗(01419) - 2025 - 年度业绩